Clinical Trials Directory

Trials / Terminated

TerminatedNCT01005459

Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE

Comparison of Spinal Tetracaine With Fentanyl and Epinephrine Versus Bupivacaine With Fentanyl and Epinephrine for Combined Spinal Epidural Labor Analgesia

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Wake Forest University · Academic / Other
Sex
Female
Age
12 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesis is that spinal tetracaine with fentanyl and epinephrine used for CSE labor analgesia volume will last a significantly longer period of time that that of spinal bupivacaine with fentanyl. After informed consent is obtained for the study, subjects meeting criteria when analgesia is requested will be randomized to receive a combined spinal-epidural containing either tetracaine 2 mg with fentanyl and epinephrine or bupivacaine 2 mg with fentanyl and epinephrine.

Conditions

Interventions

TypeNameDescription
DRUGTetracaineTetracaine 2mg will be combined with Fentanyl 20 mcg and Epinephrine 50 mcg to treat labor pain.
DRUGBupivacaineBupivacaine 2 mg combined with fentanyl 20 mcg and Epinephrine 50 mcg will be used to treat labor pain.

Timeline

Start date
2009-08-01
Primary completion
2011-12-12
Completion
2011-12-12
First posted
2009-11-02
Last updated
2017-11-08
Results posted
2017-07-13

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT01005459. Inclusion in this directory is not an endorsement.